Complete Filing Data
Cartesian Therapeutics, Inc. reported Net Income Loss of -$130.30 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cartesian Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $400.0K | $38.3M | $26.0M | $110.8M | $85.1M | $16.6M | $6.7M | $903.0K | $207.0K | $8.1M | $6.0M | $3.0M |
| Net Income Loss | -$130.3M | -$77.4M | -$219.7M | $35.4M | -$25.7M | -$68.9M | -$55.4M | -$65.3M | -$65.3M | -$36.2M | -$25.2M | -$12.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $45.0K | -$21.0K | -$53.0K | $18.0K | -$2.0K | -$40.0K | $34.0K | -$153.0K | $78.0K | $504.0K | -$1.1M | -$3.3M |
| Operating Expenses | $146.2M | $82.8M | $112.4M | $96.2M | $89.7M | $73.4M | $59.1M | $65.9M | $64.0M | $42.8M | $31.3M | $18.4M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $11.0K | -$10.0K | -$1.0K | $0.00 | $0.00 | $16.0K | $20.0K | -$36.0K | $0.00 | $0.00 | |
| Research And Development Expense | $58.0M | $45.1M | $71.3M | $72.4M | $68.7M | $54.5M | $42.7M | $47.7M | $45.2M | $29.7M | $23.0M | $10.5M |
| Operating Income Loss | -$143.4M | -$43.9M | -$86.4M | $14.5M | -$4.6M | -$56.8M | -$52.5M | -$65.0M | -$63.8M | -$34.7M | -$25.3M | -$15.4M |
| General And Administrative Expense | $31.5M | $30.1M | $40.5M | $23.9M | $20.9M | $18.9M | $16.4M | $18.2M | $18.8M | $13.1M | $8.3M | $8.0M |
| Comprehensive Income Net Of Tax | -$130.3M | -$77.4M | -$219.8M | $35.4M | -$25.7M | -$68.9M | -$55.3M | -$65.5M | -$65.2M | -$35.7M | -$26.3M | -$16.2M |
| Other Nonoperating Income Expense | -$2.0M | $606.0K | $691.0K | $330.0K | $15.0K | $89.0K | -$1.3M | $10.0K | -$152.0K | $4.0K | -$26.0K | -$44.0K |
| Interest Expense | $2.8M | $3.0M | $2.8M | $1.6M | $1.5M | $1.5M | $1.2M | $1.3M | $948.0K | $552.0K | ||
| Net Income Loss Available To Common Stockholders Basic | -$65.3M | -$65.3M | -$40.8M | -$32.5M | -$16.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $0.00 | $400.0K | $0.00 | $33.3M | $5.8M | $6.6M | $5.2M | $5.9M | $20.7M | $39.3M | $34.0M | $24.4M | $19.7M | $11.1M | $4.6M | $0.00 | $0.00 | $6.7M | $0.00 | $13.0K | $10.0K | $903.0K | $0.00 | $0.00 | $0.00 | $17.0K | $27.0K | $26.0K | $137.0K | $2.9M | $1.0M | $2.0M | $2.1M | $2.1M | $1.6M | $1.2M | $1.0M |
| Net Income Loss | -$35.9M | $15.9M | -$17.7M | -$24.2M | $13.8M | -$56.8M | -$9.0M | -$11.4M | -$21.7M | -$7.9M | $8.6M | $28.8M | -$17.9M | $4.6M | -$24.6M | -$9.7M | -$24.1M | -$19.6M | -$14.9M | -$12.0M | -$16.4M | -$12.1M | -$14.7M | -$16.0M | -$18.8M | -$15.9M | -$19.5M | -$14.7M | -$16.0M | -$15.1M | -$14.1M | -$7.7M | -$6.9M | -$7.5M | -$6.8M | -$5.7M | -$6.9M | -$5.7M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$10.0K | $12.0K | $32.0K | -$15.0K | $14.0K | -$5.0K | -$20.0K | -$27.0K | -$22.0K | -$21.0K | $118.0K | -$32.0K | -$1.0K | $12.0K | -$6.0K | -$32.0K | $31.0K | -$60.0K | -$5.0K | $7.0K | $22.0K | -$42.0K | -$90.0K | $19.0K | -$1.0K | -$43.0K | $123.0K | $15.0K | $170.0K | $231.0K | -$800.0K | $245.0K | ||||||
| Operating Expenses | $21.5M | $22.1M | $23.0M | $18.0M | $19.7M | $19.2M | $19.6M | $23.9M | $24.3M | $22.3M | $25.4M | $23.2M | $26.4M | $19.2M | $18.2M | $18.4M | $16.4M | $18.8M | $19.2M | $11.8M | $16.2M | $11.9M | $15.4M | $15.9M | $18.8M | $15.8M | $19.3M | $13.9M | $15.9M | $14.9M | $16.8M | $8.5M | $8.4M | $9.0M | $9.2M | $7.7M | $7.6M | $6.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $11.0K | -$29.0K | $0.00 | $0.00 | -$1.0K | $1.0K | -$1.0K | $0.00 | $0.00 | $0.00 | -$3.0K | $1.0K | $2.0K | $1.0K | $12.0K | $3.0K | $5.0K | $10.0K | $15.0K | $16.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Research And Development Expense | $13.8M | $14.9M | $14.7M | $11.4M | $12.7M | $9.7M | $13.0M | $17.8M | $18.6M | $16.5M | $19.2M | $17.7M | $21.0M | $14.5M | $13.0M | $14.0M | $10.7M | $14.7M | $8.1M | $12.1M | $7.4M | $11.9M | $14.4M | $11.1M | $9.5M | $11.0M | $11.0M | $6.0M | $6.0M | $6.6M | $5.5M | $5.3M | ||||||
| Operating Income Loss | -$21.1M | -$21.8M | -$21.9M | -$17.6M | $13.8M | -$13.3M | -$13.1M | -$18.6M | -$18.4M | -$1.6M | $13.9M | $10.8M | -$2.0M | $452.0K | -$7.2M | -$13.7M | -$16.4M | -$18.8M | -$11.8M | -$16.2M | -$11.9M | -$15.9M | -$18.8M | -$15.8M | -$13.9M | -$15.9M | -$14.8M | -$7.5M | -$6.4M | -$6.9M | -$6.1M | -$6.3M | ||||||
| General And Administrative Expense | $7.7M | $7.2M | $8.3M | $6.6M | $7.0M | $9.5M | $6.6M | $6.1M | $5.7M | $5.8M | $6.2M | $5.5M | $5.4M | $4.7M | $5.2M | $4.4M | $5.6M | $4.1M | $3.7M | $4.1M | $4.5M | $4.1M | $4.4M | $4.7M | $4.4M | $4.9M | $3.9M | $2.5M | $2.4M | $2.4M | $2.2M | $2.2M | ||||||
| Comprehensive Income Net Of Tax | -$35.9M | $15.9M | -$17.7M | -$24.2M | $13.9M | -$56.8M | -$9.0M | -$11.4M | -$21.7M | -$7.9M | $8.7M | $28.7M | -$17.9M | $4.6M | -$24.6M | -$9.8M | -$24.1M | -$19.7M | -$12.0M | -$16.4M | -$12.1M | -$16.0M | -$18.9M | -$15.9M | -$14.7M | -$16.0M | -$15.0M | -$7.7M | -$6.8M | -$7.2M | -$6.5M | -$6.6M | ||||||
| Other Nonoperating Income Expense | $0.00 | -$5.0K | $0.00 | $250.0K | $292.0K | $508.0K | $253.0K | $245.0K | $255.0K | $1.0K | $0.00 | $154.0K | $9.0K | $6.0K | $0.00 | $5.0K | $59.0K | -$1.0K | -$3.0K | $5.0K | -$69.0K | $3.0K | $8.0K | $0.00 | -$16.0K | $0.00 | $0.00 | $4.0K | -$64.0K | -$18.0K | -$13.0K | |||||||
| Interest Expense | $0.00 | $1.3M | $752.0K | $808.0K | $802.0K | $715.0K | $707.0K | $711.0K | $711.0K | $711.0K | $365.0K | $205.0K | $273.0K | $388.0K | $400.0K | $396.0K | $384.0K | $365.0K | $350.0K | $268.0K | $279.0K | $300.0K | $311.0K | $310.0K | $310.0K | $334.0K | $330.0K | |||||||||||
| Net Income Loss Available To Common Stockholders Basic | $13.3M | $9.6M | -$11.4M | -$12.0M | -$16.4M | -$12.1M | -$14.7M | -$16.0M | -$18.8M | -$15.9M | -$19.5M | -$14.7M | -$16.0M | -$15.1M | -$14.1M | -$7.7M | -$9.1M | -$9.8M | -$9.2M | -$7.6M | -$8.4M | -$7.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$126.2M | -$6.8M | -$440.2M | $93.8M | $22.5M | -$18.0M | $8.4M | -$5.4M | $51.8M | $55.0M | -$116.5M | -$87.8M | -$69.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $126.9M | $214.3M | $78.3M | $108.0M | $115.4M | $140.1M | $91.6M | $37.7M | $71.0M | $59.1M | $32.8M | ||
| Cash And Cash Equivalents At Carrying Value | $125.1M | $212.6M | $76.9M | $106.4M | $114.1M | $138.7M | $89.9M | $37.4M | $70.6M | $58.7M | $32.3M | $16.6M | $8.1M |
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$273.0K | -$477.0K | $147.0K | $0.00 | $52.0K | -$104.0K | $81.0K | -$36.0K | -$3.0K | $0.00 | $0.00 | |
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $79.0K | $375.0K | -$57.0K | $0.00 | $154.0K | $101.0K | -$233.0K | -$193.0K | $0.00 | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$822.4M | -$692.1M | -$614.6M | -$394.9M | -$430.3M | -$404.6M | -$335.8M | -$280.4M | -$216.9M | -$151.6M | -$111.5M | ||
| Property Plant And Equipment Net | $12.2M | $9.9M | $2.1M | $2.8M | $2.1M | $1.4M | $1.2M | $2.1M | $2.1M | $2.0M | $2.0M | ||
| Prepaid Expense And Other Assets Current | $3.0M | $3.1M | $5.0M | $3.8M | $6.5M | $5.4M | $1.5M | $4.7M | $2.0M | $2.4M | $1.5M | ||
| Liabilities Current | $14.9M | $23.0M | $68.2M | $25.1M | $72.3M | $81.5M | $34.9M | $35.1M | $11.0M | $13.7M | $7.3M | ||
| Liabilities And Stockholders Equity | $296.4M | $435.0M | $305.1M | $165.9M | $159.9M | $165.4M | $99.6M | $44.5M | $101.1M | $89.3M | $42.8M | ||
| Liabilities | $422.7M | $441.8M | $444.7M | $72.1M | $137.4M | $183.4M | $91.2M | $49.9M | $49.3M | $34.3M | $21.8M | ||
| Assets Current | $129.3M | $216.6M | $90.7M | $148.1M | $144.4M | $151.3M | $96.7M | $42.1M | $98.7M | $86.8M | $38.9M | ||
| Assets | $296.4M | $435.0M | $305.1M | $165.9M | $159.9M | $165.4M | $99.6M | $44.5M | $101.1M | $89.3M | $42.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.5M | -$4.6M | -$4.4M | -$4.5M | -$5.0M | ||
| Accounts Payable Current | $1.3M | $288.0K | $3.2M | $316.0K | $224.0K | $443.0K | $500.0K | $1.1M | $1.6M | $3.9M | $2.2M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Value | $3.0K | $3.0K | $1.0K | $15.0K | $12.0K | $11.0K | $9.0K | $3.0K | $3.0K | $1.0K | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$87.4M | $136.0M | -$29.8M | -$7.4M | -$24.6M | $48.5M | $53.9M | -$33.3M | $12.0M | $26.3M | |||
| Accounts Receivable Net Current | $1.1M | $872.0K | $5.9M | $6.6M | $9.9M | $7.2M | $5.0M | $0.00 | $215.0K | $824.0K | |||
| Restricted Cash And Cash Equivalents Noncurrent | $1.7M | $1.7M | $1.4M | $1.3M | $1.4M | $1.4M | $1.4M | $279.0K | |||||
| Repayments Of Long Term Debt | $0.00 | $27.5M | $0.00 | $0.00 | $19.3M | $2.8M | $0.00 | $12.9M | $0.00 | $2.3M | $0.00 | ||
| Finance Lease Right Of Use Asset Amortization | $778.0K | $2.4M | $1.8M | $1.3M | $1.1M | $1.1M | $1.3M | $0.00 | $0.00 | ||||
| Loans Payable Current | $0.00 | $8.5M | $6.0M | $0.00 | $18.9M | $21.4M | $0.00 | $4.1M | $0.00 | ||||
| Contract With Customer Liability Noncurrent | $0.00 | $3.5M | $0.00 | $11.4M | $38.7M | $14.7M | $13.8M | $15.9M | |||||
| Contract With Customer Liability Current | $0.00 | $2.3M | $593.0K | $53.9M | $72.1M | $1.7M | $959.0K | $787.0K | |||||
| Accrued Liabilities Current | $10.5M | $8.1M | $13.5M | $11.7M | $8.6M | $3.9M | $3.4M | ||||||
| Operating Lease Right Of Use Asset | $5.6M | $5.5M | $10.1M | $11.6M | $9.8M | $10.9M | $301.0K | ||||||
| Operating Lease Liability Current | $4.2M | $2.9M | $2.2M | $1.6M | $1.0M | $908.0K | $372.0K | ||||||
| Long Term Loans Payable | $0.00 | $17.8M | $19.7M | $24.8M | $0.00 | $0.00 | $21.0M | $8.0M | $11.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$35.8M | -$2.5M | -$21.8M | $752.0K | -$101.5M | -$116.8M | $60.3M | $65.4M | $74.6M | $84.9M | $89.6M | $55.8M | -$18.7M | -$4.2M | -$19.6M | -$7.4M | -$13.1M | -$8.8M | -$4.9M | $56.0K | $14.8M | $7.4M | $21.7M | $39.0M | $65.1M | $78.2M | $41.1M | $65.4M | $68.8M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $145.1M | $162.1M | $182.1M | $220.9M | $88.9M | $104.8M | $81.0M | $115.0M | $127.5M | $114.4M | $139.4M | $114.8M | $116.0M | $127.1M | $126.8M | $147.6M | $61.4M | $74.3M | $35.9M | $30.5M | $32.5M | $50.8M | $60.6M | $58.6M | $72.5M | $83.0M | $27.0M | |||||||
| Cash And Cash Equivalents At Carrying Value | $143.4M | $160.3M | $180.4M | $219.2M | $87.2M | $103.4M | $79.6M | $112.0M | $125.9M | $112.8M | $138.1M | $113.4M | $114.6M | $125.7M | $125.4M | $146.3M | $59.7M | $72.6M | $34.2M | $30.2M | $32.2M | $72.2M | $82.6M | $26.6M | $59.5M | $82.6M | $17.1M | $37.5M | $13.2M | |||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$2.0K | $0.00 | $147.0K | $0.00 | -$1.0K | -$70.0K | $0.00 | ||||||||||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $79.0K | -$1.0K | -$14.0K | $0.00 | $47.0K | $32.0K | -$89.0K | $0.00 | |||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$729.8M | -$693.9M | -$709.8M | -$681.8M | -$657.6M | -$671.5M | -$437.0M | -$428.0M | -$416.6M | -$400.8M | -$392.9M | -$401.5M | -$442.6M | -$424.7M | -$429.2M | -$389.2M | -$379.5M | -$355.4M | -$320.9M | -$308.9M | -$335.8M | -$263.2M | -$247.2M | -$228.4M | -$197.4M | -$182.7M | -$166.7M | -$137.5M | -$129.8M | |||||
| Property Plant And Equipment Net | $12.4M | $12.3M | $10.2M | $10.2M | $6.7M | $2.4M | $2.4M | $2.6M | $2.8M | $2.9M | $2.8M | $2.7M | $1.8M | $1.8M | $1.3M | $1.4M | $1.3M | $1.1M | $1.5M | $1.6M | $1.8M | $2.1M | $2.1M | $2.3M | $2.1M | $2.1M | $2.1M | $2.1M | $2.0M | |||||
| Prepaid Expense And Other Assets Current | $3.2M | $2.7M | $2.9M | $4.1M | $2.0M | $3.3M | $3.5M | $4.3M | $3.8M | $6.3M | $6.5M | $5.4M | $5.8M | $8.2M | $7.0M | $7.6M | $1.0M | $1.6M | $1.6M | $2.5M | $10.8M | $5.1M | $2.6M | $1.8M | $2.9M | $1.8M | $2.8M | $3.3M | $2.1M | |||||
| Liabilities Current | $13.8M | $12.3M | $15.0M | $21.4M | $26.1M | $36.7M | $19.9M | $29.4M | $26.5M | $23.7M | $33.8M | $39.2M | $95.6M | $87.3M | $84.6M | $77.0M | $22.5M | $30.1M | $29.5M | $31.9M | $33.0M | $34.6M | $13.9M | $11.8M | $11.3M | $20.1M | $13.3M | $7.7M | $8.9M | |||||
| Liabilities And Stockholders Equity | $372.7M | $388.9M | $409.1M | $455.3M | $347.7M | $325.2M | $106.0M | $139.5M | $155.7M | $178.3M | $188.1M | $145.7M | $167.2M | $180.5M | $176.7M | $181.0M | $75.2M | $88.8M | $39.5M | $46.9M | $62.5M | $60.3M | $73.4M | $89.9M | $109.7M | $117.0M | $73.9M | $85.8M | $91.3M | |||||
| Liabilities | $408.5M | $391.4M | $430.9M | $454.6M | $449.2M | $442.0M | $45.7M | $74.1M | $81.1M | $93.4M | $98.5M | $89.9M | $185.9M | $184.7M | $196.3M | $188.4M | $88.3M | $97.6M | $44.5M | $46.9M | $47.7M | $50.3M | $49.2M | $48.4M | $44.6M | $38.8M | $32.8M | $20.3M | $22.5M | |||||
| Assets Current | $147.3M | $163.4M | $185.1M | $229.1M | $124.8M | $111.1M | $89.9M | $122.7M | $138.4M | $159.7M | $172.6M | $130.0M | $151.8M | $166.8M | $163.1M | $166.5M | $61.1M | $74.4M | $36.1M | $44.4M | $59.5M | $55.6M | $68.8M | $85.0M | $107.4M | $114.6M | $71.5M | $83.4M | $89.0M | |||||
| Assets | $372.7M | $388.9M | $409.1M | $455.3M | $347.7M | $325.2M | $106.0M | $139.5M | $155.7M | $178.3M | $188.1M | $145.7M | $167.2M | $180.5M | $176.7M | $181.0M | $75.2M | $88.8M | $39.5M | $46.9M | $62.5M | $60.3M | $73.4M | $89.9M | $109.7M | $117.0M | $73.9M | $85.8M | $91.3M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.5M | -$4.5M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.6M | -$4.5M | -$4.5M | -$4.5M | -$4.5M | -$4.5M | -$4.4M | -$4.4M | -$4.4M | -$4.4M | -$4.6M | -$4.6M | |||||
| Accounts Payable Current | $2.2M | $454.0K | $2.1M | $517.0K | $2.9M | $2.5M | $375.0K | $267.0K | $1.1M | $214.0K | $693.0K | $264.0K | $1.6M | $154.0K | $594.0K | $471.0K | $1.2M | $1.3M | $1.5M | $2.5M | $693.0K | $1.3M | $1.8M | $1.8M | $1.5M | $4.3M | $1.3M | $1.0M | $943.0K | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$32.2M | $26.5M | $19.5M | -$620.0K | -$13.3M | -$17.3M | -$5.2M | -$12.4M | -$32.0M | |||||||||||||||||||||||||
| Accounts Receivable Net Current | $722.0K | $354.0K | $1.8M | $4.8M | $32.0M | $2.0M | $4.9M | $5.4M | $6.8M | $6.9M | $24.0M | $7.2M | $7.3M | $8.5M | $8.3M | $12.6M | $0.00 | $0.00 | $52.0K | $63.0K | $0.00 | $1.0K | $63.0K | $483.0K | $2.0M | |||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.4M | $1.4M | $1.4M | $1.3M | $1.6M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | ||||||||||||||||
| Repayments Of Long Term Debt | $0.00 | $2.1M | $0.00 | $0.00 | $728.0K | $0.00 | ||||||||||||||||||||||||||||
| Finance Lease Right Of Use Asset Amortization | $184.0K | $512.0K | $416.0K | $293.0K | $272.0K | $366.0K | $446.0K | |||||||||||||||||||||||||||
| Loans Payable Current | $0.00 | $10.2M | $10.2M | $5.9M | $3.3M | $696.0K | $4.1M | $2.3M | $460.0K | $0.00 | $8.4M | $16.9M | $20.9M | $21.5M | $21.5M | $21.3M | $0.00 | $4.6M | $4.5M | $2.9M | $1.8M | |||||||||||||
| Contract With Customer Liability Noncurrent | $0.00 | $0.00 | $0.00 | $4.0M | $4.9M | $5.5M | $5.4M | $7.1M | $10.4M | $20.1M | $24.7M | $32.3M | $51.5M | $16.4M | $14.7M | $15.0M | $15.0M | $13.8M | $13.8M | $12.9M | ||||||||||||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $412.0K | $4.1M | $4.2M | $4.2M | $3.8M | $16.0M | $28.0M | $62.3M | $75.0M | $75.8M | $64.4M | $1.9M | $1.7M | $1.0M | $1.0M | $959.0K | $1.9M | $1.9M | ||||||||||||||
| Accrued Liabilities Current | $13.6M | $12.9M | $9.3M | $14.1M | $12.3M | $12.4M | $8.9M | $10.7M | $8.9M | $6.8M | $11.3M | $9.3M | $8.8M | $5.3M | $5.8M | $8.5M | $10.2M | $10.2M | $9.1M | $6.5M | $8.6M | $5.5M | $2.4M | $4.7M | ||||||||||
| Operating Lease Right Of Use Asset | $5.0M | $5.2M | $5.4M | $13.5M | $13.9M | $9.6M | $10.3M | $10.8M | $11.2M | $12.1M | $9.2M | $9.5M | $10.1M | $10.4M | $10.7M | $11.2M | $11.5M | $11.8M | $594.0K | $878.0K | $1.2M | |||||||||||||
| Operating Lease Liability Current | $3.9M | $3.8M | $3.7M | $2.8M | $2.5M | $2.2M | $1.8M | $1.7M | $1.7M | $1.6M | $1.1M | $1.1M | $1.0M | $977.0K | $942.0K | $875.0K | $1.6M | $1.4M | $734.0K | $1.1M | $1.4M | |||||||||||||
| Long Term Loans Payable | $0.00 | $13.8M | $16.2M | $20.2M | $22.6M | $25.0M | $21.3M | $22.9M | $24.6M | $24.6M | $6.4M | $0.00 | $21.2M | $21.1M | $21.0M | $5.7M | $6.9M | $9.1M | $10.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $10.5M | $6.6M | $22.5M | $11.2M | $7.7M | $5.4M | $5.2M | $5.7M | $4.1M | $2.1M | $1.1M | $1.2M |
| Financing Cash Flow * | -$8.1M | $168.4M | -$13.1M | $39.2M | $52.9M | $14.4M | $105.0M | $697.0K | $66.0M | $67.7M | $43.9M | $24.8M |
| Investing Cash Flow * | -$5.5M | -$8.7M | $34.6M | -$15.0M | -$17.1M | -$741.0K | $229.0K | $25.3M | -$2.1M | -$22.1M | -$4.7M | -$227.0K |
| Operating Cash Flow * | -$73.9M | -$23.7M | -$51.2M | -$31.6M | -$60.4M | $34.9M | -$51.4M | -$59.2M | -$52.0M | -$19.8M | -$22.5M | -$12.7M |
| Proceeds From Stock Options Exercised | $323.0K | $1.2M | $0.00 | $156.0K | $778.0K | $193.0K | $150.0K | $501.0K | $706.0K | $149.0K | $109.0K | $137.0K |
| Payments To Acquire Property Plant And Equipment | $5.5M | $9.1M | $206.0K | $1.2M | $1.1M | $815.0K | $47.0K | $884.0K | $733.0K | $586.0K | $1.2M | $227.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.3M | -$1.7M | $1.3M | -$2.5M | $1.5M | $4.4M | -$3.2M | $2.6M | -$1.2M | $831.0K | $1.0M | $404.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.6M | -$6.7M | -$2.8M | $2.2M | $1.1M | -$2.8M | -$2.4M | $2.5M | $5.7M | $716.0K | $1.3M | $415.0K |
| Increase Decrease In Accounts Payable | $1.1M | -$2.9M | $2.8M | $92.0K | -$219.0K | -$57.0K | -$600.0K | -$516.0K | -$2.3M | $2.7M | $667.0K | -$90.0K |
| Increase Decrease In Accounts Receivable | $243.0K | -$5.0M | -$726.0K | -$3.3M | $2.7M | $2.2M | $5.0M | $0.00 | -$152.0K | -$610.0K | $153.0K | $514.0K |
| Proceeds From Stock Plans | $0.00 | $231.0K | $189.0K | $161.0K | $184.0K | $28.0K | $196.0K | $180.0K | $0.00 | $0.00 | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$5.8M | $5.3M | -$64.7M | -$45.5M | $94.5M | $337.0K | -$101.0K | $2.4M | $10.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $2.5M | $1.4M | $2.3M | $2.8M | $1.8M | $1.4M | $1.2M | $1.5M | $1.3M | $1.2M | $1.3M | $863.0K | $693.0K | $633.0K | $367.0K | $282.0K | $252.0K | $315.0K |
| Financing Cash Flow * | -$8.0M | $43.0M | $149.0K | $1.7M | $21.3M | -$5.4M | $31.1M | $51.0K | -$292.0K | -$1.7M | ||||||||
| Investing Cash Flow * | -$1.1M | -$602.0K | $28.1M | $9.5M | -$22.4M | -$135.0K | -$16.1M | $945.0K | -$16.5M | -$3.6M | ||||||||
| Operating Cash Flow * | -$23.1M | -$15.9M | -$8.8M | -$11.9M | -$12.1M | -$11.7M | -$20.2M | -$13.4M | -$15.3M | -$10.2M | ||||||||
| Proceeds From Stock Options Exercised | $183.0K | $154.0K | $0.00 | $21.0K | $244.0K | $3.0K | $145.0K | $0.00 | $436.0K | $7.0K | ||||||||
| Payments To Acquire Property Plant And Equipment | $1.1M | $602.0K | $130.0K | $455.0K | $25.0K | $135.0K | $0.00 | $192.0K | $58.0K | $143.0K | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.8M | -$1.7M | $20.0K | -$853.0K | $1.5M | $61.0K | $6.2M | -$417.0K | $316.0K | $35.0K | ||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.2M | -$6.4M | -$5.4M | -$2.2M | -$1.7M | -$829.0K | -$3.6M | $404.0K | $1.4M | -$581.0K | ||||||||
| Increase Decrease In Accounts Payable | $1.8M | -$633.0K | $747.0K | $18.0K | $151.0K | $836.0K | -$407.0K | $180.0K | -$2.6M | -$424.0K | ||||||||
| Increase Decrease In Accounts Receivable | $893.0K | -$3.9M | $243.0K | -$2.8M | $1.1M | -$5.0M | $0.00 | -$11.0K | -$152.0K | $805.0K | ||||||||
| Proceeds From Stock Plans | $0.00 | $149.0K | $127.0K | $72.0K | $114.0K | $20.0K | $51.0K | $0.00 | ||||||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$5.4M | $9.2M | -$26.9M | -$2.7M | $0.00 | -$2.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.02 | -$4.49 | -$49.76 | $0.10 | -$0.22 | -$0.68 | -$1.22 | -$2.92 | -$3.20 | -$3.89 | -$15.13 | -$7.84 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 62.2M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 9.4M | 9.5M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | ||
| Common Stock Shares Outstanding | 26.0M | 25.8M | 5.4M | 153.0M | 123.6M | 108.1M | 86.3M | 22.5M | 22.3M | 18.4M | 2.2M | |
| Common Stock Shares Issued | 26.0M | 25.8M | 5.4M | 153.0M | 123.6M | 108.1M | 86.3M | 22.5M | 22.3M | 18.4M | 2.2M | |
| Weighted Average Number Of Shares Outstanding Basic | 26.0M | 17.3M | 5.2M | 144.8M | 114.3M | 101.2M | 45.5M | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 101.2M | 45.5M | 22.4M | 20.4M | 10.5M | 2.2M | 2.1M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 26.0M | 17.4M | 5.2M | 145.9M | 114.3M | 101.2M | 45.5M | |||||
| Earnings Per Share Basic | $-5.02 | $-4.48 | $-49.76 | $0.24 | $-0.22 | $-0.68 | $-1.22 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.38 | $0.50 | -$0.68 | -$1.13 | $0.54 | -$10.50 | -$1.74 | -$2.23 | -$4.24 | -$0.05 | $0.06 | $0.08 | -$0.16 | $0.00 | -$0.22 | -$0.09 | -$0.25 | -$0.21 | -$0.28 | -$0.26 | -$0.37 | -$0.31 | -$0.65 | -$0.71 | -$0.84 | -$0.71 | -$0.88 | -$0.66 | -$0.85 | -$0.82 | -$0.77 | -$0.43 | -$2.75 | -$4.52 | -$4.26 | -$3.50 | -$3.93 | -$3.43 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Preferred Stock Shares Authorized | 9.4M | 9.4M | 9.4M | 9.4M | 9.4M | 9.8M | 9.5M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||
| Common Stock Shares Outstanding | 26.0M | 26.0M | 25.9M | 23.9M | 17.8M | 5.5M | 154.9M | 153.4M | 153.4M | 153.0M | 152.7M | 124.4M | 115.4M | 115.1M | 113.0M | 107.2M | 100.8M | 87.0M | 48.2M | 45.0M | 44.8M | 22.4M | 22.4M | 22.3M | 22.1M | 22.1M | 18.6M | 18.2M | 17.9M | ||||||||||
| Common Stock Shares Issued | 26.0M | 26.0M | 25.9M | 23.9M | 17.8M | 5.5M | 154.9M | 153.4M | 153.4M | 153.0M | 152.7M | 124.4M | 115.4M | 115.1M | 113.0M | 107.2M | 100.8M | 87.0M | 48.2M | 45.0M | 44.8M | 22.4M | 22.4M | 22.3M | 22.1M | 22.1M | 18.6M | 18.2M | 17.9M | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 26.0M | 26.0M | 25.9M | 21.5M | 16.7M | 5.4M | 5.2M | 5.1M | 5.1M | 152.8M | 148.5M | 124.2M | 115.2M | 113.5M | 110.7M | 105.3M | 96.8M | ||||||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 110.7M | 105.3M | 96.8M | 94.7M | 46.4M | 44.9M | 38.4M | 22.4M | 22.4M | 22.3M | 22.1M | 18.8M | 18.5M | 18.3M | 18.1M | 3.3M | 2.2M | 2.2M | 2.2M | 2.1M | 2.1M | ||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 26.0M | 26.4M | 25.9M | 21.5M | 17.8M | 5.4M | 5.2M | 5.1M | 5.1M | 152.8M | 148.5M | 127.6M | 115.2M | 121.2M | 110.7M | 105.3M | 96.8M | ||||||||||||||||||||||
| Earnings Per Share Basic | $-1.38 | $0.51 | $-0.68 | $-1.13 | $0.58 | $-10.50 | $-1.74 | $-2.23 | $-4.24 | $-0.05 | $0.06 | $0.23 | $-0.16 | $0.04 | $-0.22 | $-0.09 | $-0.25 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Net | $5.0M | $2.1M | $44.0K | $260.0K | $834.0K | $1.1M | $617.0K | $234.0K | $171.0K | $111.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.5M | $6.6M | $21.0M | $10.2M | $7.7M | $5.4M | $5.2M | $5.7M | $4.1M | $2.0M | $1.1M | $1.2M |
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $38.0K | -$22.0K | $0.00 | $56.0K | -$47.0K | $120.0K | -$123.0K | -$525.0K | $933.0K | $3.0M | |
| Fair Value Adjustment Of Warrants | -$3.7M | -$2.6M | -$12.7M | -$20.9M | $2.3M | $10.4M | $857.0K | $0.00 | $0.00 | $12.0K | -$83.0K | $38.0K |
| Stock Issued During Period Value Stock Options Exercised | $298.0K | $1.2M | $156.0K | $778.0K | $193.0K | $150.0K | $501.0K | $705.0K | $149.0K | $86.0K | $68.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $18.0K | $847.0K | $128.0K | $17.0K | $224.0K | $4.0K | $0.00 | $145.0K | $103.0K | $147.0K | $0.00 | $0.00 |
| Paid In Kind Interest | $0.00 | $455.0K | $953.0K | $1.0M | $620.0K | $402.0K | $449.0K | $390.0K | $263.0K | $198.0K | $155.0K | |
| Additional Paid In Capital | $700.7M | $689.9M | $179.1M | $493.3M | $457.4M | $391.2M | $348.7M | $279.5M | $273.1M | $211.1M | $1.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $231.0K | $189.0K | $161.0K | $184.0K | $28.0K | $196.0K | $180.0K | |||||
| Interest Paid Net | $0.00 | $1.9M | $2.2M | $2.0M | $1.0M | $1.2M | $1.1M | $905.0K | $972.0K | |||
| Depreciation | $726.0K | $975.0K | $750.0K | $802.0K | $1.0M | $864.0K | ||||||
| Other Depreciation And Amortization | $3.0M | $1.2M | $843.0K | $1.3M | $1.3M | $734.0K | $726.0K | $975.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Net | $1.5M | $1.7M | $2.0M | $2.6M | $1.2M | $1.2M | $1.3M | $1.4M | $1.3M | $710.0K | $207.0K | $15.0K | $11.0K | $12.0K | $12.0K | $4.0K | $13.0K | $240.0K | $184.0K | $246.0K | $277.0K | $295.0K | $246.0K | $288.0K | $165.0K | $101.0K | $113.0K | $98.0K | $10.0K | $13.0K | $25.0K | $62.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.6M | $3.3M | $2.5M | $1.7M | $1.6M | $1.4M | $2.3M | $2.3M | $2.3M | $2.6M | $2.6M | $2.8M | $1.9M | $1.8M | $1.8M | $1.3M | $1.5M | $1.4M | $1.3M | $1.3M | $1.2M | $1.5M | $1.2M | $1.2M | $693.0K | |||||||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $0.00 | $0.00 | -$3.0K | $23.0K | $19.0K | $15.0K | -$104.0K | $28.0K | $2.0K | -$14.0K | $7.0K | $43.0K | -$42.0K | $82.0K | $7.0K | -$10.0K | -$30.0K | $26.0K | $84.0K | -$13.0K | -$30.0K | $82.0K | -$165.0K | -$51.0K | -$158.0K | -$220.0K | $668.0K | -$246.0K | |||
| Fair Value Adjustment Of Warrants | -$516.0K | -$654.0K | -$1.8M | -$5.7M | $3.9M | -$1.0M | -$3.8M | -$6.3M | $4.1M | $6.5M | $4.6M | -$18.5M | -$592.0K | -$4.8M | $16.7M | -$4.8M | $7.5M | $846.0K | $0.00 | $0.00 | $0.00 | $0.00 | $20.0K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $5.0K | $85.0K | $183.0K | $56.0K | $120.0K | $154.0K | $135.0K | $21.0K | $5.0K | $425.0K | $244.0K | $98.0K | $3.0K | $5.0K | $145.0K | $109.0K | $311.0K | $436.0K | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $535.0K | $0.00 | $48.0K | $91.0K | $10.0K | $10.0K | $0.00 | $142.0K | $125.0K | $0.00 | ||||||||||||||||||||||
| Paid In Kind Interest | $0.00 | $398.0K | $383.0K | $387.0K | $123.0K | $189.0K | $177.0K | $144.0K | $41.0K | |||||||||||||||||||||||
| Additional Paid In Capital | $698.5M | $695.9M | $692.6M | $687.2M | $560.8M | $559.3M | $501.9M | $498.0M | $495.7M | $490.3M | $487.0M | $461.9M | $428.4M | $425.0M | $414.2M | $386.4M | $370.9M | $351.2M | $320.5M | $313.4M | $311.8M | $277.7M | $275.9M | $274.3M | $266.8M | $265.3M | $212.2M | $207.5M | $203.1M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $82.0K | $149.0K | $62.0K | $127.0K | $89.0K | $72.0K | $70.0K | $114.0K | $8.0K | $20.0K | $145.0K | $51.0K | $0.00 | |||||||||||||||||||
| Interest Paid Net | $0.00 | $625.0K | $494.0K | $494.0K | $232.0K | $312.0K | $261.0K | |||||||||||||||||||||||||
| Depreciation | $100.0K | $200.0K | $231.0K | $200.0K | $200.0K | $181.0K | $200.0K | $400.0K | $169.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $178.0K | $200.0K | $500.0K | |||||||||||||||
| Other Depreciation And Amortization | $1.2M | $183.0K | $206.0K | $351.0K | $207.0K | $231.0K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.